Which brings us back to Steak 'n Shake. The fast-food chain has officially declared that it's transitioning away from seed ...

The Cat Lawyer, baked feta pasta, a bizarre monolith and Stanley Tucci’s Negroni recipe were among the things that delighted ...

U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. plans to meet top executives of several major food firms on ...

Musk is regularly using ketamine—a dissociative anesthetic known for its hallucinogenic effects, cognitive impairment risks, ...

With ESG and “woke” policies on the decline at many corporations, one activist investor believes the next big opportunity is ...

ASX companies with approval applications in train appear to be okay, but it’s nervous times for the rest Optimists believe the overly bureaucratic FDA processes may be streamlined for the better ...

Followed categories will be added to My News. This week’s sackings and re-hirings at the FDA suggest limits to the Trump administration’s efficiency drive ASX companies with approval ...

This month, the head of the FDA resigned, according to a Bloomberg report. Jim Jones, the former head of the FDA, said the agency's layoffs show that the current administration is unserious.

This designation is for the treatment of adult patients with recurrent or metastatic head and neck squamous cell ... and is committed to working with the FDA to advance this therapy efficiently.

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.